Get started
Author

Xiaobin Wang

ORCID: 0000-0002-1948-7061
Observed ORCID: 0000-0002-1948-7061
OpenAlex ID: A5073840778
Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al. · Cancer Research · 15
SRT3025-loaded cell membrane hybrid liposomes (3025@ML) enhanced anti-tumor activity of Oxaliplatin via inhibiting pyruvate kinase M2 and fatty acid synthase
2025 · Xiaobin Wang, Shulin Li, et al. · Lipids in Health and Disease · 8
PDF
Urine-Derived Stem Cells Attenuate Post-Injury Urethral Fibrosis in Association With Reduced Smad3/JunD Signaling Activation, Inflammation, and Extracellular Matrix Remodeling
2026 · Liangliang Huang, Yuhui Yao, et al. · Discovery Medicine
Epigenetic and DNA-repair programs in corpus cavernosum endothelium: genome stability and erectile dysfunction
2026 · Zichen Li, Xiaobin Wang · Genome Instability & Disease
Unraveling the Causal Association Between Circulating Copper Levels and Erectile Dysfunction: A Comprehensive Analysis via Bidirectional Two Sample Mendelian Randomization Study
2025 · Zilong Wang, Zhen Xu, et al. · Food Science & Nutrition
PDF
Supplementary Figure 3 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Supplementary Figure 3 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 7 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 5 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 8 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 4 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Data from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 8 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Supplementary Materials and Methods from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Table 2 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Table 1 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Table 1 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Table 2 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Supplementary Materials and Methods from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Supplementary Table 3 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Supplementary Table 4 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 7 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
PDF
Data from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Table 3 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Supplementary Figure 2 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024 · Yongheng Chen, Ying Ying, et al.
Works count: 63
Citation count: 23
H-index: 2
I10-index: 1
Year
Topic
Type